Company / PP&E (Net)
HealthEquity PP&E (Net) History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$3.2M
FY2026
5-year range
$3.2M / $23.4M
FY2022-FY2026
Trend
+0.0%
vs FY2025
Sector context
#125 of 130
Health Care
What the data says
Among 130 Health Care companies, HealthEquity is in the bottom 4% for pp&e (net).
Based on SEC 10-K filings.
$3M in FY2026 with a 5-year CAGR of -35.8%.
Remained stable around $3M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -19.2%
- 5-Year CAGR
- -35.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 130This company $3.2M Sector average $1.3B
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -35.8%, indicating a declining trend.
- In FY2026, pp&e (net) increased 0.0% year-over-year.
- Ranks #125 out of 130 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | $3.2M | +0.0% |
| FY2025 | $3.2M | -1.9% |
| FY2024 | $3.2M | -46.1% |
| FY2023 | $6.0M | -74.3% |
| FY2022 | $23.4M | -19.7% |
| FY2021 | $29.1M | +0.0% |
| FY2020 | $29.1M | -13.1% |
| FY2019 | $33.5M | +307.2% |
| FY2018 | $8.2M | +4.9% |
| FY2017 | $7.8M | +51.6% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026